Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
about
Coronary heart disease and hormone replacement therapy after the menopauseEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for strokeA Dormant Microbial Component in the Development of PreeclampsiaPostmenopausal hormones and coronary artery disease: potential benefits and risksMenopause and stroke and the effects of hormonal therapyMultivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohortsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesComparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment.An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.Data analysis methods and the reliability of analytic epidemiologic researchResearch into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular DiseaseHealth risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Middle cerebral artery occlusion model in rodents: methods and potential pitfalls.A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.IMS updated recommendations on postmenopausal hormone therapy.Transplantation of young ovaries restored cardioprotective influence in postreproductive-aged mice.Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohortTrajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectiveSex hormones and the cardiovascular system: effects on arterial function in women.Vascular and metabolic effects of sex steroids: new insights into clinical trials.Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational studyPostmenopausal hormone therapy and cardiovascular disease in perspective.Women's Health Initiative diet intervention did not increase macular pigment optical density in an ancillary study of a subsample of the Women's Health Initiative.Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.Changes in experimental stroke outcome across the life spanDietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative.Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.The risk of stroke in postmenopausal women receiving hormonal therapy.Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens' cardioprotective effect through atherosclerosis prevention.Primary prevention of cardiovascular disease with HRT.Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy.Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.Embedding clinical interventions into observational studies.Combining randomized and non-randomized evidence in clinical research: a review of methods and applications.
P2860
Q22248005-3547A108-3A92-4298-BF99-77FBEB0FED72Q24658109-B1C18420-6311-4A91-BE7B-99300208FCD9Q27012615-799B5D38-6882-4E70-A2B9-71E800C45DDEQ28069689-97D17C7F-A86B-4CD5-B99E-71FB859094D6Q28221869-B124F5AA-663B-483C-B681-445CA3634FCEQ28221875-61BE521E-168C-4EAE-9575-ABB7DD601497Q28308282-3AF5C90F-A022-4E2E-B458-E2DCCE08B0D7Q28388335-05EF69E0-59FB-443C-9BD9-E49F0642E75CQ30655662-DB77FCE6-7E13-4095-892A-43D72344D83FQ30696956-7EE24BED-E1A7-46DD-A66F-AD97A322352DQ33371496-15DFE428-B34D-4329-BBF4-EF4B56A84132Q34043346-AE2C806C-D1BD-4C3E-887D-CB58B069C38AQ34315268-F29682C9-0AB7-455B-A4B7-E078289B28B7Q34420014-B0994C6D-4317-4293-8B7F-6BFFE85DC7D7Q34558344-BF01D21B-0EB8-4608-A435-917B9FA55404Q34612394-6B4DA008-BB95-4FFF-94C7-C184059B2F70Q34626471-A0FB34FA-3DC3-4B40-98FC-95A6BE718676Q35008013-6B67BC68-8379-4FFD-8DF7-862CB454003DQ35737915-CFCB24B9-6BBE-4AAE-ADC8-2DF1D36F2337Q36753585-18EEC9F1-7940-48CF-AD08-724A1806760BQ36781520-6E622F2B-D404-487B-8B94-20D0F7B8D66BQ36854152-0DBFD745-443F-40C0-8025-4BE8630CD581Q36888620-C4157B92-A071-40ED-91F0-C15AB38E6A07Q36970351-5CFCB752-CA96-4DA2-830F-39AB62427842Q37163009-31EA3038-FF7A-4601-9C5B-26913A07B779Q37209821-CA975E01-9737-4264-8340-CFD20BCA1669Q37234323-E7ACA738-B266-4E9C-BAC6-4504095EE582Q37309855-8D7EC617-67B4-4E9C-BF42-07C50130CC92Q37321697-ADA7BE2B-B92C-4C07-9A5B-1B69EF3A1FCDQ37356917-5A6F1524-3188-414F-A0B1-5FB18024CD2CQ37377187-1EB1D125-0B28-448F-9FFB-E74D86BEE1A1Q37446677-813514A1-C1B2-484D-8772-DF1B68DE3A68Q37610401-AB9A19B0-94F8-4F4C-A49B-F33A9B66935AQ37721919-C71A43C1-BEE3-492F-B7AF-CDE8C700C5F9Q37968650-0888B8FF-AFEE-40D8-8EB4-8224F17A9108Q37994253-747AB23C-E93E-4CF1-9A8A-323BD6D65A0DQ38011779-0450FDA8-EB9C-485D-BC35-CBA742B78508Q38106748-2C134603-EC50-4E2E-83E7-9A121C0FF26DQ38384869-745CC6F9-2750-405F-A079-0E46E65900B1Q38512940-5E836448-EF0C-4413-B90E-45D358E6F07A
P2860
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combined analysis of Women's H ...... nt and cardiovascular disease.
@ast
Combined analysis of Women's H ...... nt and cardiovascular disease.
@en
type
label
Combined analysis of Women's H ...... nt and cardiovascular disease.
@ast
Combined analysis of Women's H ...... nt and cardiovascular disease.
@en
prefLabel
Combined analysis of Women's H ...... nt and cardiovascular disease.
@ast
Combined analysis of Women's H ...... nt and cardiovascular disease.
@en
P2093
P2860
P50
P356
P1476
Combined analysis of Women's H ...... nt and cardiovascular disease.
@en
P2093
David Barad
Garnet L Anderson
J David Curb
Jane Kotchen
Marcia L Stefanick
Marian Limacher
Mary Pettinger
Ross L Prentice
Women's Health Initiative Investigators
P2860
P304
P356
10.1093/AJE/KWJ079
P407
P50
P577
2006-02-16T00:00:00Z